| NCT Number | NCT06880991 |
| Lead Sponsor | National Cancer Institute (NCI) |
| Conditions | Neurofibromatosis Type 1, Neurofibroma |
| Enrollment | 110 participants |
| Start Date | 2025-04-29 |
| Primary Completion | 2027-03-31 (estimated) |
| Study Completion | 2028-03-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-14 |